'Expectations on Every Calorie:' How PepsiCo's CEO Is Navigating GLP-1s and Inflation

Ramon Laguarta sees opportunities in smaller-portion products and teas for mental focus.

AstraZeneca, Ionis Shares Slide After Wainua Misses Target in Heart Disease Trial

The drugmakers said the drug didn't meet its primary objective in a Phase 3 trial when treating a rare type of heart disease.

Prologis Pushes for Talks on $16.9 Billion Segro Bid